NCT07503327 Effectiveness of Telerehabilitation in Ankylosing Spondylitis
| NCT ID | NCT07503327 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Inonu University |
| Condition | Anklyosing Spondylitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 66 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 66 participants in total. It began in 2025-08-01 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Purpose of the study: Ankylosing spondylitis (AS) is a chronic disease that affects the spine and joints, causing pain, stiffness, fatigue, and reduced quality of life. Exercise is known to help reduce pain and improve function in individuals with AS. However, the most effective type and method of exercise are not fully known. This study aims to compare the effects of different telerehabilitation methods-synchronous (live video) and asynchronous (pre-recorded video)-on disease activity, physical function, mobility, fatigue, quality of life, kinesiophobia (fear of movement), and pain levels in individuals with AS. Study design and methods: This is a randomized controlled experimental study. Participants will be randomly assigned to one of three groups: Synchronous telerehabilitation: Exercise sessions via live video, 3 times per week for 8 weeks. Asynchronous telerehabilitation: Exercise sessions via pre-recorded videos, 3 times per week for 8 weeks. Control group: Exercise instructions provided in a brochure. All groups will perform exercises for approximately 40-50 minutes per session, focusing on flexibility, strength, posture, balance, coordination, and functional movements. Participants will be evaluated before the intervention (week 0) and after 8 weeks for disease activity, physical function, mobility, fatigue, quality of life, kinesiophobia, and pain during rest, movement, and sleep. Participants: The study will include adults aged 18-65 years diagnosed with AS at least one year prior, able to use a smartphone, and willing to participate. Individuals who are pregnant, have serious comorbidities, recent surgery, or conditions affecting mobility will be excluded. Expected benefits: The study will identify which telerehabilitation method is more effective for individuals with AS. telerehabilitation may provide easier access to treatment, improve adherence to exercise programs, and contribute to better disease management and quality of life.
Eligibility Criteria
Inclusion Criteria: * Being between the ages of 18-65 * Having been diagnosed with Ankylosing Spondylitis by a specialist at least one year ago, * Agreeing to participate in the study voluntarily, * Owning and being able to use a smartphone, * Being able to read and write. Exclusion Criteria: * Having a history of pregnancy, malignancy, or recent surgery (within the last six months) * Having a history of hypertension and diabetes that cannot be controlled with medication * Having a history of exacerbations in the last three weeks and having received treatment for exacerbations * Having instable medical treatment within the last three months * Having any orthopedic, neurological, or mental illness that would affect exercise * Having any assistive device for ambulation * Having participated in any exercise-based intervention program within the last month Exclusion Criteria * Failure to attend three consecutive treatment sessions, * Failure to complete the tests and questionnaires, * Voluntarily withdrawing from the study.
Frequently Asked Questions
Who can join the NCT07503327 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 65 Years, studying Anklyosing Spondylitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07503327 currently recruiting?
Yes, NCT07503327 is actively recruiting participants. Visit ClinicalTrials.gov or contact Inonu University to inquire about joining.
Where is the NCT07503327 trial being conducted?
This trial is being conducted at Elâzığ, Turkey (Türkiye).
Who is sponsoring the NCT07503327 clinical trial?
NCT07503327 is sponsored by Inonu University. The trial plans to enroll 66 participants.